The global hyperphosphatemia treatment market, which was valued at USD 2.58 billion in 2022, is poised for steady growth, projected to reach USD 3.84 billion by 2030. This anticipated growth reflects a compound annual growth rate (CAGR) of 5.1% over the forecast period spanning from 2023 to 2030.
Hyperphosphatemia is a medical condition characterized by abnormally high levels of phosphate...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek